Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids

Keyphrases

• Tumor 100%
• Precision Medicine 100%
• Drug Sensitivity 100%
• On-a-chip 100%
• Patient-derived Organoids 100%
• Cell Proliferation 66%
• Tumor Cells 66%
• Angiogenesis 66%
• Cancer Treatment 66%
• Tumor Metastasis 66%
• Tumor Progression 66%
• Cell Migration 66%
• Tumor Growth 33%
• Clinically Significant 33%
• Patient-derived 33%
• Migration Cell 33%
• Personalized Medicine 33%
• Tumor Cell Lines 33%
• Cell Tumor 33%
• Cell-derived 33%
• Treatment Strategy 33%
• Tumor Microenvironment 33%
• Capillary 33%
• Drug Discovery 33%
• Tumor Patients 33%
• Vascular Network 33%
• Chemotherapy Sensitivity 33%
• Antiangiogenic Therapy 33%
• Tumor Drugs 33%
• Primary Breast Tumor 33%
• Tumor Organoids 33%
• Sprouting Angiogenesis 33%
• Microfluidic Platform 33%
• In Vitro Device 33%
• Tumor Cell Intravasation 33%
• Mass Transport 33%
• Culture Growth 33%
• Breast Cancer Organoid 33%
• 3D Vascular Network 33%
• Cell Intravasation 33%
• Physiological Delivery 33%

Medicine and Dentistry

• Neoplasm 100%
• Personalized Medicine 100%
• Cell Line 100%
• Organoid 100%
• Drug Sensitivity 100%
• Tumor Cell 75%
• Tumor Progression 75%
• Cancer Therapy 50%
• Cell Proliferation 50%
• Metastatic Carcinoma 50%
• Angiogenesis 50%
• Intravasation 50%
• Malignant Neoplasm 25%
• In Vitro 25%
• Tumor Cell Line 25%
• Breast Cancer 25%
• Capillary 25%
• Breast Tumor 25%
• Cell Migration 25%
• Tumor Microenvironment 25%
• Microvessel 25%
• Target Cell 25%
• Vascular Network 25%
• Antiangiogenic Therapy 25%
• Sprouting Angiogenesis 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Tumor Growth 37%
• Malignant Neoplasm 37%
• Metastasis 25%
• Breast Cancer 12%
• Breast Tumor 12%
• Tumor Microenvironment 12%
• Drug Discovery 12%
• Antiangiogenic Therapy 12%
• Mass Transfer 12%